Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines
- PMID: 34319350
- DOI: 10.1001/jama.2021.12915
Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines
Similar articles
-
Neutralizing SARS-CoV-2.Elife. 2020 Dec 15;9:e64496. doi: 10.7554/eLife.64496. Elife. 2020. PMID: 33320086 Free PMC article.
-
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.N Engl J Med. 2021 Apr 8;384(14):1372-1374. doi: 10.1056/NEJMc2101667. Epub 2021 Mar 10. N Engl J Med. 2021. PMID: 33691060 Free PMC article. No abstract available.
-
Audio Interview: A Look at Covid-19 Prevention and Care in 2020.N Engl J Med. 2020 Dec 31;383(27):e147. doi: 10.1056/NEJMe2036225. N Engl J Med. 2020. PMID: 33382936 No abstract available.
-
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system.Microbes Infect. 2020 Nov-Dec;22(10):515-524. doi: 10.1016/j.micinf.2020.09.004. Epub 2020 Sep 19. Microbes Infect. 2020. PMID: 32961274 Free PMC article. Review.
-
A review of monoclonal antibodies in COVID-19: Role in immunotherapy, vaccine development and viral detection.Hum Antibodies. 2021;29(3):179-191. doi: 10.3233/HAB-200441. Hum Antibodies. 2021. PMID: 33998533 Review.
Cited by
-
Characterization of pathogen-inactivated COVID-19 convalescent plasma and responses in transfused patients.Transfusion. 2022 Oct;62(10):1997-2011. doi: 10.1111/trf.17083. Epub 2022 Sep 5. Transfusion. 2022. PMID: 36054476 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
